Immunostimulatory monoclonal antibodies for hepatocellular carcinoma therapy: Trends and perspectives
Medicina (B.Aires); 78 (1), 2018
Hepatocellular carcinoma (HCC) is the second cause of cancer-related death in the world and is the main cause of death in cirrhotic patients. Unfortunately, the incidence of HCC has grown significantly in the last decade. Curative treatments such as surgery, liver transplantation or percutaneous ablation...
Anticuerpos Monoclonales/uso terapéutico, Antineoplásicos Inmunológicos/uso terapéutico, Carcinoma Hepatocelular/tratamiento farmacológico, Ensayos Clínicos como Asunto, Inmunoterapia/métodos, Neoplasias Hepáticas/tratamiento farmacológico, Nivolumab/uso terapéutico, Compuestos de Fenilurea/uso terapéutico, Piridinas/uso terapéutico, Sorafenib/uso terapéutico